So casting ahead, how achievable is it to envisage isonea with a $140m cap? Thats a ten bagger from here.
Thomas talks of one billion cap. One tenth of that will do.
I figure they only need 1% of the 20% of kids and elderly with asthma to get the sort of revenue they need for this sort of valuation. Sleep monitoring could be huge given the recurring revenue model once mooted. Upside everywhere i look.
Can thomas get the experts aboard?
ISN Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held